OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 80 filers reported holding OCULAR THERAPEUTIX INC in Q4 2019. The put-call ratio across all filers is 0.24 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $73,195 | +88.2% | 13,889 | +0.4% | 0.00% | – |
| Q4 2022 | $38,888 | -39.2% | 13,839 | -10.1% | 0.00% | – |
| Q3 2022 | $64,000 | -85.0% | 15,394 | -41.0% | 0.00% | -100.0% |
| Q1 2021 | $428,000 | -12.5% | 26,083 | +10.5% | 0.00% | 0.0% |
| Q4 2020 | $489,000 | +244.4% | 23,600 | +26.9% | 0.00% | – |
| Q3 2020 | $142,000 | +91.9% | 18,600 | -0.6% | 0.00% | – |
| Q4 2019 | $74,000 | +48.0% | 18,713 | +14.1% | 0.00% | – |
| Q3 2019 | $50,000 | -3.8% | 16,400 | +37.8% | 0.00% | – |
| Q2 2019 | $52,000 | -42.2% | 11,900 | -18.5% | 0.00% | – |
| Q3 2017 | $90,000 | +25.0% | 14,600 | +87.2% | 0.00% | – |
| Q2 2017 | $72,000 | 0.0% | 7,800 | 0.0% | 0.00% | – |
| Q1 2017 | $72,000 | +188.0% | 7,800 | +160.0% | 0.00% | – |
| Q4 2016 | $25,000 | +257.1% | 3,000 | +200.0% | 0.00% | – |
| Q3 2016 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,944,761 | $23,898,000 | 100.00% |
| Opaleye Management Inc. | 5,974,800 | $24,019,000 | 10.83% |
| DELTEC ASSET MANAGEMENT LLC | 2,069,313 | $8,319,000 | 1.95% |
| Kamunting Street Capital Management, L.P. | 275,506 | $1,108,000 | 1.50% |
| Altium Capital Management LP | 695,000 | $2,794,000 | 1.12% |
| Endurant Capital Management LP | 760,228 | $3,056,000 | 1.07% |
| EMERALD ADVISERS, LLC | 1,465,702 | $5,892,000 | 0.30% |
| MSD Partners, L.P. | 1,016,302 | $4,086,000 | 0.25% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,044,732 | $4,200,000 | 0.24% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $781,000 | 0.11% |